Eledon Pharmaceuticals Stock Analysis

Eledon Stock Analysis Notes

About 43.0% of the company shares are held by institutions such as insurance companies. The book value of Eledon Pharmaceuticals was currently reported as 1.85. The company has Price/Earnings To Growth (PEG) ratio of 0.01. Eledon Pharmaceuticals last dividend was issued on the 5th of October 2020. The entity had 1:18 split on the 5th of October 2020. Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis , and requiring an organ or cell-based transplant. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California. Eledon Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. To learn more about Eledon Pharmaceuticals call the company at (949) 238-8090 or check out https://eledon.com.

Eledon Pharmaceuticals Investment Alerts

Eledon Pharmaceuticals Upcoming and Recent Events

Eledon Largest EPS Surprises

View All Earnings Estimates

Eledon Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Eledon Pharmaceuticals Thematic Classifications

Eledon Stock Institutional Investors

Note, although Eledon Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Eledon Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 278.39 M.

Eledon Profitablity

Management Efficiency

Eledon Pharmaceuticals has return on total asset (ROA) of (0.3336) % which means that it has lost $0.3336 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2536) %, meaning that it created substantial loss on money invested by shareholders. Eledon Pharmaceuticals' management efficiency ratios could be used to measure how well Eledon Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of December 2024, Return On Tangible Assets is likely to drop to -0.75. In addition to that, Return On Capital Employed is likely to drop to -0.53. At this time, Eledon Pharmaceuticals' Non Current Assets Total are very stable compared to the past year. As of the 1st of December 2024, Non Currrent Assets Other is likely to grow to about 309.2 K, while Total Assets are likely to drop about 81.1 M.

Technical Drivers

As of the 1st of December, Eledon Pharmaceuticals shows the Downside Deviation of 3.53, mean deviation of 3.62, and Coefficient Of Variation of 565.26. Eledon Pharmaceuticals technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Eledon Pharmaceuticals Price Movement Analysis

Eledon Pharmaceuticals Insider Trading Activities

Eledon Pharmaceuticals Outstanding Bonds

Eledon Pharmaceuticals Predictive Daily Indicators

Eledon Pharmaceuticals Corporate Filings

Eledon Pharmaceuticals Forecast Models

Eledon Pharmaceuticals' time-series forecasting models are one of many Eledon Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Eledon Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Eledon Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Eledon shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Eledon Pharmaceuticals. By using and applying Eledon Stock analysis, traders can create a robust methodology for identifying Eledon entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Eledon analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Eledon analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Eledon Pharmaceuticals stock analysis indicators help investors evaluate how Eledon Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Eledon Pharmaceuticals shares will generate the highest return on investment. By understating and applying Eledon Pharmaceuticals stock analysis, traders can identify Eledon Pharmaceuticals position entry and exit signals to maximize returns.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eledon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eledon Pharmaceuticals. If investors know Eledon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eledon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Eledon Pharmaceuticals is measured differently than its book value, which is the value of Eledon that is recorded on the company's balance sheet. Investors also form their own opinion of Eledon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eledon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eledon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eledon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Eledon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eledon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eledon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.